Dapsone (Nostrum Laboratories, Inc.)
Welcome to the PulseAid listing for the Dapsone drug offered from Nostrum Laboratories, Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nostrum Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Dapsone |
| SUBSTANCE NAME: | DAPSONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-05-09 |
| END MARKETING DATE: | 0000-00-00 |
Dapsone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dapsone from Nostrum Laboratories, Inc. |
| LABELER NAME: | Nostrum Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2016-05-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 29033-036_4f1d3dc1-e6d3-4a07-89bd-1d552f63ce10 |
| PRODUCT NDC: | 29033-036 |
| APPLICATION NUMBER: | ANDA203887 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers:
